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The concept of the presence of passageways, chreodes, created by the influence of the hydropathic states of amino acid side chains
on the surface water of proteins, has been proposed. These chreodes facilitate and direct the diﬀusion of neurotransmitters through
surface water, to the receptor or active site on a protein. This system of chreodes is vulnerable to the presence of some other
molecules that may encounter the chreode system. This encounter and disruption has been proposed to explain the mechanism of
general anesthesia. Based on much recent evidence of the similarities between anesthesia from volatile anesthetic agents and sleep,
a comparable mechanism has been proposed for sleep. Since this must be an exogenous substance to be comparable to a general
anesthetic agent, it was proposed that this exogenous, sleep-producing substance is elemental nitrogen. Recent evidence supports
these hypotheses.
1. Ligand Diffusion
A fundamental process in all living systems is the movement
of molecules toward each other, followed by frequent en-
counters and changes in their states. Invariably this move-
ment, or diﬀusion, takes place in water. This movement
is influenced by attributes associated with these molecules
and other features that they encounter along the way. It
is appreciated that a two-dimensional diﬀusion near the
protein surface, relative to a three-dimensional diﬀusion in
bulk water, enhances the rate of movement in this process [1–
3]. In the case of a ligand molecule encountering an eﬀector,
the approach of the ligand initially comes to the surface of
the protein housing the eﬀector. This system is typical of a
transmitter-receptor or substrate-enzyme system. Early stud-
ies [4] of this process proposed a change in local water viscos-
ity on the protein surface playing a role in the rate of enzy-
matic reactions. This influence on water viscosity changes
was demonstrated using circular dichroism studies [5]. This
viscosity change was proposed to create a change in the struc-
ture of bulk water on the protein surface leading to a facilita-
tion of the diﬀusion of a substrate to the enzyme active site.
A model of this process was created [6] in which a ligand
approaches a receptor and becomes engaged in a pool or
pathway near the receptor. This example focused on the
sweet-tasting receptor. Residence of sweet-tasting molecules
in this pathway or pool was proposed to explain the phenom-
enon of persistence of the taste when the system was washed
out. This persistence phenomenon is encountered in many
ligand-eﬀector systems. The concept provides an argument
for a possible diﬀusion direction influence existing near the
protein surface as well as a persistent presence of a ligand
near the receptor. These studies lead to the possibility that
structural features on the protein surface may influence the
water near the surface in a way that guidance and diﬀusion
facilitation of a ligand to an eﬀector is achieved. Reflection on
this possibility leads to a conclusion that molecule-molecule
interactions in a living system cannot be random events.
Consider a vast protein network functioning collectively on
a macroscale. The encounters must be focused, occur on a
narrow temporal scale, and be highly selective to minimize
interfering encounters.
This complex issue was recently addressed [7]. A pro-
posal was put forward that the surface of a protein, con-
taining a variety of amino acid side chains, was influencing
the water in the vicinity of the surface. This influence is
due to the hydropathic states of each side chain. The twenty
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amino acids have a rich variety of this attribute ranging from
very hydrophobic to very hydrophilic. See Table 1. A series of
models of water in the presence of these side chains showed
that this side chain attribute can influence the organization
of water in the vicinity. These studies began with the use of
an agent-basedmodeling system known as cellular automata,
to model bulk water [8]. A valid model of bulk water was
achieved leading to a series of modeling studies dealing with
water, solutes, and stationary side chains in bulk water [9–
12]. The models revealed a strong influence of side chains
on the organized state of nearby bulk water. Interpreting
these as side chain characteristics, it was proposed that
distinct patterns of side chains on the surface of an active
protein may exist [7]. These patterns were proposed to create
diﬀusion influences on the water near the protein surface.
Since water is approximately 1/3 void, these spaces may be
organized from the variety of hydropathic states present to
create a pathway, called a chreode, facilitating diﬀusion [7].
The consequences of such a chreode are to retain a ligand
near the protein surface and to facilitate its diﬀusion to the
eﬀector. If the eﬀector is an enzyme, the encounter with the
substrate may be followed by a rapid diﬀusion of the product
away from the enzyme via the presence of a chreode that
has evolved to carry out this function. Thus an enzymatic
reaction is fast due to rapid approach of the substrate and a
rapid departure of the product from the enzyme.
Several characteristics are postulated to be associated
with each chreode near a particular eﬀector. Each chreode
is selective for a particular eﬀector on a particular protein,
thus the chreodes found on a protein associated with an
acetylcholine receptor, will be found on all such proteins
and will have some specificity for the acetylcholine using
that chreode. The chreode may be viewed as part of the
eﬀector with a role of a diﬀusion facilitator. A chreode
is not a fixed pathway on the protein surface. It is an
evanescent structure that forms, breaks up, and forms again,
but with some regularity it retains a basic organization
permitting the diﬀusion of the ligand to the eﬀector. Finally
the chreode associated with a particular eﬀector might play a
role in excluding a nonfunctioning molecule with a structure
diﬀerent from that molecule associated with the eﬀector.
Models of the chreode concept showed the eﬀect on the
diﬀusion rates of solutes simulating ligands [13–15]. Other
models of the chreode influence on diﬀusion, revealed that
other molecules randomly dispersed among the chreodes
and ligands produced a reduction in the diﬀusion rate [13].
The potential susceptibility of the chreodes to functional
alteration led to an hypothesis of the mechanism of action
of volatile anesthetic agents [16].
2. General Anesthesia
The nonspecific, volatile, general anesthetic agents repre-
sented by diethyl ether, nitrous oxide, and the halothanes
have been used and studied for many years. Early explana-
tions of their actions focused on their lipophilic character
related to the aqueous and fatty tissues in the body [17, 18].
Some proposed mechanisms have recently been summarized
[19]. The possibility of a cell membrane being the target
Table 1: Hydropathic states of amino acid side chains.
Amino Acid Hydrophobicitya
Arg −1.01
Lys −0.99
Asp −0.77
Glu −0.64
Asn −0.60
Gln −0.22
Ser −0.04
Gly 0.00
His 0.13
Thr 0.26
Ala 0.31
Tyr 0.96
Val 1.22
Met 1.23
Cys 1.54
Leu 1.70
Phe 1,79
Ile 1,80
Trp 2.25
a
Pi values calculated: J. Fauchere, M. Charton, L. Kier, A Verloop, and V.
Pliska. Amino acid side chain parameters for correlation studies in biology
and pharmacology. Int. J. Protein Res. 32, 269–278 [1988]. The negative
values are hydrophilic; the positive values are hydrophobic.
for a volatile anesthetic agent has been refuted by evidence
that stereoisomers have a small diﬀerence in potency [20–
22]. The role of membranes as targets would require a far
higher concentration than those used clinically [23, 24]. The
possibility of a protein specific target has been considered but
rejected on the basis of concentrations needed to produce
anesthesia [25–27]. The possible involvement of specific
receptors has been considered. These include gamma-amino
butyric acid [GABA] [20, 28]. Anesthetic agents employed do
not produce a response pattern characteristic of direct GABA
receptor behavior [29–32]. Other proposals invoke the role of
several binding sites such as glutamate and acetylcholine [33,
34]. Other studies illustrate the roles of gases in producing
anesthesia [35, 36].
Further evidence of multiple binding sites comes from a
steep dose-response eﬀect [37]. Tolerance is not experienced
with volatile anesthetic agents, an attribute usually experi-
enced with drugs acting at specific receptors. The evidence to
date leads to the current view that volatile anesthetic agents
produce a series of weak binding events near several diﬀerent
receptors. The response observed transcends any specific
receptor and is due to a complex summation of modest
eﬀects from several receptors. This concept led to a consider-
ation of the chreodes associated with several diﬀerent recep-
tor systems as targets of volatile anesthetic agents [7, 16].
3. A Chreode Theory of General Anesthesia
The nature of water chreodes, just defined, suggests a possible
target for a molecule that can interrupt or interfere with
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their function. Each volatile anesthetic agent is relatively
inert chemically, has a modest size, and is moderately
hydrophobic. Each chreode system, hypothesized to exist in
support of a receptor, is potentially vulnerable to alteration
by some other molecules. This is possible because the
chreode existence is postulated to be entirely dependent
upon hydrophobic and hydrophilic attributes of the amino
acid side chains on the receptor protein, creating it. A theory
of this interference with the chreode structure by a volatile
anesthetic agent has been proposed [16]. This interference
with chreodes leads to a reduction in their function, which
is to facilitate and direct transmitter molecule diﬀusion to
its receptor. The variety of these receptor types influenced,
and the modest degree of the interference, is compati-
ble with the current understanding of general anesthetic
mechanisms [19, 26]. The inspired volatile anesthetic agent
diﬀuses through a large part of the body, encountering
several neurotransmitter systems. It interferes with several
systems by altering the chreode function in each system to
some extent. The sum of these ligand diﬀusion alterations
produces the observed level of general anesthetic response,
analgesia, anesthesia, amnesia, and muscle function loss
[16]. At the end of the anesthetic administration, there is
a decline in the concentration of this agent throughout the
body, leading to a recovery of the chreode functions and a
recovery of the neurotransmitter systems that they have been
influencing. At some point, there is a return to consciousness
and a recovery of the systems inhibited in the patient.
4. General Anesthesia and Sleep
There is an emerging awareness of the similarities between
general anesthesia and sleep [38–41]. These similarities
include physiological and behavioral patterns. Both sleep and
anesthesia involve wakefulness mediated in the CNS [38–
40]. The pons has been implicated in arousal states [42, 43].
The cholinergic system in the pons has been identified in
the arousal state [44, 45]. Sleep is a coordinated response of
anesthesia characteristics such as analgesia, unconsciousness,
muscle relaxation, and amnesia [46]. General anesthesia
interferes with CNS cholinergic systems [23, 47–49], and
acetylcholine is more prominent during awake periods than
during sleep [44, 45, 50]. In non-REM sleep and anesthesia,
the cholinergic system is less active in the pons [51, 52]. The
changing of inhaled nitrogen with helium at normal pres-
sures could influence sleep as shown in some studies [53, 54].
These observations of the similarities between anesthesia
and sleep led to a hypothesis that a comparable mechanism
is operating, centered on neurotransmitters such as acetyl-
choline, GABA, glutamate, and others. The prime targets are
likely in the CNS with peripheral eﬀects certainly operating.
It raises the possibility that sleep is produced by an agent
outside of the body, capable of interfering with processes that
are operational during waking and anesthetic-free periods.
5. A Theory of Sleep
The origin of sleep has been proposed, based on the
roles of chreodes and the similarities between sleep and
anesthesia produced by the volatile anesthetic agents [55].
It was proposed that the basic mechanism is the same, the
interference of chreodes associated with several critical neu-
rotransmitters, discussed above. These transmitters are in the
CNS and elsewhere where muscle function may be interfered
with. An exogenous substance, playing a role comparable
to a general anesthetic agent, operates to produce sleep. It
was proposed that this exogenous substance is elemental
nitrogen, N2 [55]. Nitrogen is 78% of the air we breathe. It is
ubiquitous in our bodies and along with oxygen it enters and
leaves our bodies in a respiratory cycle.
Nitrogen is chemically inert, not participating in any bio-
chemical or biophysical process identified to date. Nitrogen
is a major ingredient taken in with every breath and is largely
expelled by the same process. It is proposed that there is a
slow accumulation of a small excess of N2 in the body over
the course of a wakeful period of time. This nitrogen content
is distributed everywhere in the body. In some locations,
the nitrogen becomes available to interfere with chreodes
associated with functional systems. These events mimic the
proposed role of a volatile anesthetic agent that interferes
with chreodes associated with the function of critical neuro-
transmitters. In the case of nitrogen, this interference is a
much more subtle eﬀect, called sleep.
During sleep there is a reduction in the respiration
rate, dropping to about 75% of the wakeful rate. This rate
change produces a reduction in the accumulation of excess
nitrogen which leads to a decline in the chreode influence
on transmitter diﬀusion. The outcome of this change is a
return to the normal function of the receptors. This is the
onset of wakefulness. During the sleep period, there are
episodic declines in the eﬀect of nitrogen on the chreodes,
producing a shift in the sleep attributes toward wakefulness.
These episodes are referred to as rapid eye movements
[REM]. As the sleep period progresses, the length of the
REM experiences becomes longer until ultimately, the level
of nitrogen in the chreodes becomes permanently insuﬃcient
to reduce the chreode function, and wakefulness occurs.
It is known that nitrogen will produce a low level of
anesthesia but a high pressure must be used [56]. The con-
clusion of that study was the reinforcement of the concept
that an agent, including nitrogen, acting as an anesthetic, is
nonspecific in its targets. The potency exhibited by nitrogen
in that study was low and so the low level of anesthesia
achieved through breathing would account for the charac-
teristics of sleep. Other observations support this hypothesis.
It is observed that patients with sleep deprivation require
significantly less general anesthetics to produce anesthesia
[57]. A study of the eﬀect of nitrogen on ion channel currents
revealed an eﬀect identical to that from a general anesthetic
agent [58, 59]. It is now recognized that there is no clear
evidence of a species that does not sleep [60]. The occurrence
of sleep is reported in the fly, D. melanogaster [61, 62], zebra
fish [63, 64], and the worm C. elegans [65].
Evidence is presented in this paper of the existence of
chreodes facilitating ligand diﬀusion over protein surfaces.
That diﬀusion is proposed to be interrupted by general
anesthetics to produce anesthesia and by inhaled nitrogen
to produce sleep. Each concept bears further evaluation
4 Biochemistry Research International
of experimental evidence. Such novel hypotheses present a
challenges for further study.
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